←Back to Expert Scholars
Translational Medicine / 转化医学Metastatic Breast Cancer, Endocrine Therapy
Virginia Kaklamani
MD, DSc
🏢UT Health San Antonio MD Anderson Cancer Center🌐USA
Professor of Medicine
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Virginia Kaklamani has led clinical trials of endocrine therapy combinations and PI3K inhibitors in hormone receptor-positive metastatic breast cancer. She is a long-standing leader of the San Antonio Breast Cancer Symposium. She continues to direct breast oncology research at UT Health San Antonio.
Share:
🧪Research Fields 研究领域
metastatic breast cancer
CDK4/6 inhibitors
endocrine therapy
PI3K inhibitors
SABCS
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Virginia Kaklamani 的研究动态
Follow Virginia Kaklamani's research updates
留下邮箱，当我们发布与 Virginia Kaklamani（UT Health San Antonio MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment